Notice of Intent to Sole Source - iSeq 100 Advance

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Illumina, Inc. The Illumina DNA sequencers are utilized in the high-throughput DNA sequencing of public health pathogens and outbreak samples. No other direct vendors have been identified which offer or are able to support maintenance of these instruments. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement. This notice of intent is not a request for competitive quotations; however, all responses received within five (5) days of the issuance of this notice will be reviewed by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response should be emailed to contract specialist at [email protected] by COB 07/16/2021.